Tyra Biosciences Inc (TYRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,152 | -11,880 | -55,325 | -42,430 | -29,921 |
| Depreciation Amortization | 172 | 83 | 296 | 214 | 132 |
| Other Working Capital | 556 | -483 | -5,847 | -3,771 | -2,966 |
| Other Operating Activity | 4,962 | 2,433 | 10,591 | 7,682 | 6,662 |
| Operating Cash Flow | $-19,462 | $-9,847 | $-50,285 | $-38,305 | $-26,093 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -84 | -41 | -559 | -538 | -490 |
| Investing Cash Flow | $-84 | $-41 | $-559 | $-538 | $-490 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 746 | 376 | 632 | 629 | 265 |
| Financing Cash Flow | $746 | $376 | $632 | $629 | $265 |
| Beginning Cash Position | 252,213 | 252,213 | 302,425 | 302,425 | 302,425 |
| End Cash Position | 233,413 | 242,701 | 252,213 | 264,211 | 276,107 |
| Net Cash Flow | $-18,800 | $-9,512 | $-50,212 | $-38,214 | $-26,318 |
| Free Cash Flow | |||||
| Operating Cash Flow | -19,462 | -9,847 | -50,285 | -38,305 | -26,093 |
| Capital Expenditure | -84 | -41 | -559 | -538 | -490 |
| Free Cash Flow | -19,546 | -9,888 | -50,844 | -38,843 | -26,583 |